Prime Medicine, Inc. PRME

Rank #2461 · Nasdaq · $0.9B market cap

⚠ Going-concern flag — the auditor (PricewaterhouseCoopers LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.

Score

16.3

P/E

-4.4

P/B

6.41

ROE

-147.2%

Op. Margin

-6787.4%

Debt Ratio

108%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Poor

P/E -4.4x, P/B 6.41x. Ranks in the top 81% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -147.2%. Ranks in the top 98% of the universe.

Safety ★★★☆☆

Average

Debt ratio 108%. Ranks in the top 42% of the universe.

Growth –

No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2022	$0.0B	$-0.0B	$-0.0B	$-0.0B	-17.9	-2398
2023	–	$-0.1B	$-0.1B	$-0.2B	–	-28
2024	$0.0B	$-0.2B	$-0.2B	$0.3B	–	19
2025	$0.0B	$-0.2B	$-0.2B	$0.1B	-6787.4	108

← See the full screener